The Role of Serum Matrix Metalloproteinase - 9 as a Prognostic Biomarker for Short-Term Outcome in Acute Ischemic Stroke

Serum Level of Ferritin and Fibrinogen as Prognostic Indicator for Acute Ischemic Stroke

Relationship between plasma MatrixMetalloProteinase-9 (MMP-9) and hemorrhagictransformation in acute ischemic stroke

ASSESSMENT OF THE SERUM INTERLEUKIN-6, INTERCELLULAR ADHESION MOLECULE-1, NITRIC OXIDE AND C-REACTIVE PROTEIN IN ACUTE ISCHEMIC STROKE

The relation between matrix metalloprotinase-9 as a biomarker of acute ischemic stroke and stroke outcome

Matrix Metalloproteinase 2 and Interleukin 29 as Novel Biochemical Markers for Neurovascular Complications among Type 2 Diabetic Elderly Patients

VALUE OF MATRIX METALLOPROTEINASE AS A PREDICTOR OF OUTCOME OF ACUTE MYOCARDIAL INFARCTION

Serum level of Matrix metalloproteinase-9 in patients with systemic lupus erythematosus.

Correlation between serum tight junction proteins with blood brain barrier integrity in ischemic stroke patients

Study of Hyperglycemia as a Prognostic Factor in Acute Ischemic Stroke